Education
About Us
Working with TipRanks
Follow Us
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -560.00K | $ -529.00K |
| Operating Income | $ -54.39M | $ -36.93M | $ -29.77M |
| EBITDA | $ -51.71M | $ -34.75M | $ -29.38M |
| Net Income | $ -52.67M | $ -35.31M | $ -29.51M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 110.76M | $ 29.88M | $ 11.54M |
| Total Assets | $ 114.91M | $ 35.73M | $ 16.00M |
| Total Debt | $ 1.08M | $ 674.00K | $ 637.00K |
| Net Debt | $ -109.68M | $ -29.20M | $ -10.91M |
| Total Liabilities | $ 11.08M | $ 137.58M | $ 70.42M |
| Stockholders' Equity | $ 103.83M | $ -101.84M | $ -54.42M |
| Cash Flow | |||
| Free Cash Flow | $ -51.17M | $ -34.79M | $ -28.09M |
| Operating Cash Flow | $ -51.12M | $ -34.55M | $ -26.95M |
| Investing Cash Flow | $ 15.87M | $ -246.00K | $ -1.13M |
| Financing Cash Flow | $ 116.13M | $ 53.13M | $ 26.46M |